Alexander Pasternak

4.3k citations

88 papers · 2.5k indexed · h-index 30

Co-authors: Ben Berkhout Willy J. M. Spaan Eric J. Snijder Vladimir V. Lukashov Margreet Bakker Suzanne Jurriaans Mary Struthers Jan M. Prins
Topics: HIV Research and Treatment (45 papers)HIV/AIDS drug development and treatment (29 papers)HIV/AIDS Research and Interventions (22 papers)
Cited by: Virology Infectious Diseases Animal Science and Zoology
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Nature Communications
Partner nations: Netherlands United States Belgium

In The Last Decade

Alexander Pasternak

86 papers receiving 2.5k citations

Peers

Countries citing papers authored by Alexander Pasternak

Since Specialization

Citations

This map shows the geographic impact of Alexander Pasternak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Pasternak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Pasternak more than expected).

Fields of papers citing papers by Alexander Pasternak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Pasternak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Pasternak. The network helps show where Alexander Pasternak may publish in the future.

Co-authorship network of co-authors of Alexander Pasternak

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Pasternak. A scholar is included among the top collaborators of Alexander Pasternak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Pasternak. Alexander Pasternak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency 2025 ·Nature Communications ·Alexandra Dorman,(unknown),(unknown),(unknown),(unknown),(unknown),Paolo Maiuri,(unknown),Monika Bociąga‐Jasik,(unknown),Coca Necsoi,Stéphane De Wit,Véronique Avettand-Fènoël,Alessandro Marcello,Krzysztof Pyrć,Alexander Pasternak,Carine Van Lint,Anna Kula	1
2	Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption 2025 ·AIDS ·(unknown),Anders Boyd,Alexander Pasternak,Irma Maurer,(unknown),Marlous L. Grijsen,Suzanne Jurriaans,Jan M. Prins,Neeltje A. Kootstra,Godelieve J. de Bree	1
3	Live cell screening to identify RNA-binding small molecule inhibitors of the pre-let-7–Lin28 RNA–protein interaction 2024 ·RSC Medicinal Chemistry ·(unknown),(unknown),George M. Giambaşu,(unknown),Alexander Pasternak,Erin F. DiMauro,(unknown),Amanda L. Garner	5
4	Towards a molecular profile of antiretroviral therapy-free HIV remission 2022 ·Current Opinion in HIV and AIDS ·(unknown),Ben Berkhout,Alexander Pasternak	2
5	Identification of Potent Reverse Indazole Inhibitors for HPK1 2021 ·ACS Medicinal Chemistry Letters ·(unknown),Joey L. Methot,Xavier Fradera,Charles A. Lesburg,Brian M. Lacey,Phieng Siliphaivanh,Ping Liu,Dustin Smith,Zangwei Xu,Jennifer Piesvaux,Shuhei Kawamura,Haiyan Xu,J. Richard Miller,Mark Bittinger,Alexander Pasternak	24
6	Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds 2021 ·ACS Medicinal Chemistry Letters ·Brandon Vara,Samuel M. Levi,(unknown),David A. Candito,Xavier Fradera,Charles A. Lesburg,Shuhei Kawamura,Brian M. Lacey,Jongwon Lim,Joey L. Methot,Zangwei Xu,Haiyan Xu,Dustin Smith,Jennifer Piesvaux,J. Richard Miller,Mark Bittinger,Sheila Ranganath,David Jonathan Bennett,Erin F. DiMauro,Alexander Pasternak	31
7	Assessing proviral competence: current approaches to evaluate HIV-1 persistence 2021 ·Current Opinion in HIV and AIDS ·(unknown),Ben Berkhout,Alexander Pasternak	6
8	Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function 2020 ·PLoS ONE ·Yun Wang,Kelvin Zhang,Peter Georgiev,Steven B. Wells,Haiyan Xu,Brian M. Lacey,Zangwei Xu,Jason Laskey,Robbie L. McLeod,Joey L. Methot,Mark Bittinger,Alexander Pasternak,Sheila Ranganath	29
9	Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion 2019 ·Nature Communications ·Marilia Rita Pinzone,Jake VanBelzen,(unknown),Maria Paola Bertuccio,(unknown),Emmanuele Venanzi Rullo,Stephen A. Migueles,R. Brad Jones,Talia M. Mota,Sarah Joseph,Kevin Groen,Alexander Pasternak,Wei‐Ting Hwang,Brad T. Sherman,Anastassios Vourekas,Giuseppe Nunnari,Una O’Doherty	121
10	Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3 2018 ·mBio ·(unknown),Lavina Gharu,Anna Kula,Alexander Pasternak,Véronique Avettand-Fènoël,Christine Rouzioux,(unknown),Stéphane De Wit,Monsef Benkirane,Ben Berkhout,Carine Van Lint,Alessandro Marcello	30
11	The Inwardly Rectifying Potassium Channel Kir1.1: Development of Functional Assays to Identify and Characterize Channel Inhibitors 2012 ·Assay and Drug Development Technologies ·John P. Felix,Birgit T. Priest,Kelli Solly,Timothy Bailey,Richard M. Brochu,(unknown),Martin Köhler,László Kiss,Magdalena Alonso‐Galicia,Haifeng Tang,Alexander Pasternak,Gregory J. Kaczorowski,María L. García	5
12	Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities 2010 ·Bioorganic & Medicinal Chemistry Letters ·Haifeng Tang,(unknown),Zhe Feng,(unknown),Lihu Yang,Dorothy Levorse,Karen Owens,Taro E. Akiyama,Raynald Bergeron,Gino Castriota,Thomas W. Doebber,Kenneth Ellsworth,Michael E. Lassman,Li Cai,Margaret Wu,Bei B. Zhang,Kevin T. Chapman,Sander G. Mills,Joel P. Berger,Alexander Pasternak	13
13	Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia 2010 ·AIDS ·Alexander Pasternak,Suzanne Jurriaans,Margreet Bakker,Ben Berkhout,Vladimir V. Lukashov	22
14	Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome 2009 ·PLoS ONE ·Alexander Pasternak,Suzanne Jurriaans,Margreet Bakker,Jan M. Prins,Ben Berkhout,Vladimir V. Lukashov	77
15	Conformational studies of 3-amino-1-alkyl-cyclopentane carboxamide CCR2 antagonists leading to new spirocyclic antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Alexander Pasternak,(unknown),George A. Doss,Nancy N. Tsou,Gabor Butora,Pasquale P. Vicario,Julia M. Ayala,Mary Struthers,Julie A. DeMartino,Sander G. Mills,Lihu Yang	10
16	Discovery of 3,5-bis(trifluoromethyl)benzyl l-arylglycinamide based potent CCR2 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Lihu Yang,Changyou Zhou,Liangqin Guo,Gregori J. Morriello,Gabor Butora,Alexander Pasternak,William H. Parsons,Sander G. Mills,Malcolm MacCoss,Pasquale P. Vicario,Hans J. Zweerink,Julia M. Ayala,Shefali Singla,William A. Hanlon,Margaret A. Cascieri,Marty S. Springer	20
17	The μ-opioid receptor subtype is required for the anorectic effect of an opioid receptor antagonist 2006 ·European Journal of Pharmacology ·Ping Zhang,Andrea Frassetto,Ruey-Ruey C. Huang,Julie Lao,Alexander Pasternak,Shengping Wang,Joseph M. Metzger,Alison M. Strack,Tung M. Fong,Richard Z. Chen	15
18	4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties 2006 ·Bioorganic & Medicinal Chemistry Letters ·Gabor Butora,Gregori J. Morriello,(unknown),(unknown),Alexander Pasternak,William H. Parsons,Malcolm MacCoss,Pasquale P. Vicario,Margaret A. Cascieri,Lihu Yang	30
19	Transport Characteristics of Peptidomimetics. Effect of the Pyrrolinone Bioisostere on Transport Across Caco-2 Cell Monolayers 1998 ·Pharmaceutical Research ·Masao Sudoh,Giovanni M. Pauletti,Wenqing Yao,William Moser,Akihisa Yokoyama,Alexander Pasternak,Paul A. Sprengeler,Amos B. Smith,Ralph Hirschmann,Ronald T. Borchardt	18
20	An Orally Bioavailable Pyrrolinone Inhibitor of HIV-1 Protease: Computational Analysis and X-ray Crystal Structure of the Enzyme Complex 1997 ·Journal of Medicinal Chemistry ·Amos B. Smith,Ralph Hirschmann,Alexander Pasternak,Wenyan Yao,Paul A. Sprengeler,M. Katharine Holloway,Lawrence C. Kuo,Zhongguo Chen,(unknown),William A. Schleif	47

About Alexander Pasternak

Alexander Pasternak is a scholar working on Virology, Infectious Diseases and Immunology, having authored 88 papers that have together received 2.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (45 papers), HIV/AIDS drug development and treatment (29 papers) and HIV/AIDS Research and Interventions (22 papers). The work is most often cited by research in Virology (1.0k citations), Infectious Diseases (1.2k citations) and Animal Science and Zoology (399 citations). Alexander Pasternak has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Ben Berkhout, Willy J. M. Spaan, Eric J. Snijder, Vladimir V. Lukashov, Margreet Bakker, Suzanne Jurriaans, Mary Struthers, Jan M. Prins, Amos B. Smith and Ralph Hirschmann. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact